The defining go-to-market questions here are not about channels: which clinical or scientific segment to win first, how the product is bought and reimbursed, what evidence you need to earn adoption, and how to say any of it within the claims you are cleared to make. We build that foundation, positioning within cleared claims, ICP and segment focus, the business-model and reimbursement view, and an evidence-and-credibility-driven motion, in coordination with your regulatory and MLR function. We do not make medical claims; we make the go-to-market coherent, compliant, and tied to real outcomes.
We work through your core GTM questions, segment, model, reimbursement, evidence, and the claims boundary, with you and your regulatory and MLR function, and pressure-test your current positioning against the sector's realities, so we know what to resolve before anything ships.
We benchmark against the evidence-driven, multi-stakeholder, long-cycle B2B tech companies we have run GTM for, adapted to medtech's regulation and reimbursement, so the strategy starts from evidence rather than a commercial-SaaS template.
We make the calls: positioning within cleared claims, the segments to win first, the business-model and reimbursement view, the evidence strategy, and the credibility-first motion, prioritized by which adoption moves revenue given your stage and evidence.
We turn the strategy into the assets and plan to run it, positioning, evidence and credibility architecture, segment and account plans, and the channel sequence, cleared through MLR, and can operate it through the rest of the growth stack.
As the motion runs, we read the CRM and your teams' signals, which segments adopt, which evidence and reimbursement objections stall deals, how KOLs and institutions respond, and refine positioning, segment focus, and channel mix. GTM becomes a living operating model tied to qualified pipeline.
We have built go-to-market for 60+ B2B tech companies with technical, evidence-driven, multi-stakeholder, long-cycle buyers. We know how to resolve positioning, segment focus, and model for complex sales, and we apply it to the compliant, evidence-led side of medtech, where evidence, KOLs, reimbursement, and trust weigh even heavier, in coordination with your experts.
In the first weeks we work through the core questions, segment focus, business model and reimbursement, evidence strategy, and the claims boundary, with you and your regulatory and MLR function, so you get a resolved, actionable GTM foundation fast, instead of a strategy that ignores the sector's realities.
GTM strategy is worthless as a document, so ours ends in an evidence-and-credibility-first plan we can run, KOL, scientific content, ABM, on the compliant side. Because we operate the full B2B tech growth stack within your constraints, we sequence the motion instead of leaving execution as your problem.
Strategy that ignores reality is fiction, and here reality includes the evidence bar and the constraints. We ground positioning, segment focus, and model in what your commercial, scientific, and regulatory teams see, which segments adopt, which evidence and reimbursement objections stall deals, what is cleared to say, and refine as those signals come in.
We wire the GTM to the outcomes that matter here, qualified pipeline through clinical evaluation, reimbursement, and procurement, in your CRM, over a long horizon. That keeps strategy honest and the spend it directs defensible, the discipline behind $30M+ in CRM-tracked, marketing-led revenue across our clients.
Strategy first, channels second, sales feedback always. We measure by the qualified demand and revenue we can trace back inside the CRM.
Our founder led their marketing as Head of Marketing, running a 7-person team across SEO, demand gen, and paid — $1M/year in marketing revenue. Re-engaged in 2026 and halved cost per MQL and SQL.
ServicesFractional CMO · SEO · Demand Generation · Paid Ads
Senior operators on every account. Never a junior pod.
Rebuilt inbound from scratch — 100% YoY SQL growth, 207% more traffic, domain rating from 12 to 45, and 141 articles shipped.
ServicesFractional CMO · SEO · Demand Generation
“We've seen a 207% increase in web traffic and our domain rating improved from 12 to 45.”
Took a referral-only firm to a real new-business engine — 5 deals and $240K revenue from Meta in a year, plus 2–4 SQLs/month from ChatGPT.
ServicesMeta Ads · Fractional CMO · AI Search
“Their expertise and proactiveness have impressed our team.”
Positioned them as the recommended Salesforce partner inside the major LLMs — two $1M enterprise deals closed from ChatGPT in a 3-month engagement.
ServicesAI Search · Fractional CMO · Meta Ads
“They operated with the discipline and initiative of an internal senior marketer.”
Built the marketing function from zero — website, SEO, paid, AI search — from 166 to 2,513 monthly clicks and 3 enterprise deals won.
ServicesFractional CMO · SEO · AI Search · Meta Ads
“They defined a clear marketing strategy and established our unique value proposition.”
Turned Salesforce-niche SEO into a deal channel — 2.73× traffic and MQL-to-SQL conversion up from 17% to 29%.
ServicesSEO · Content Marketing
“We have started receiving our first inbound requests.”
Restructured the marketing team and shifted to lead-driving SEO — doubling client count and growing SQLs 133% in nine months.
ServicesSEO · Fractional CMO
Switched them from brand-awareness content to lead-driving SEO — 20 of 25 service pages ranked top 5 and the first deals closed from organic.
ServicesSEO · Fractional CMO · Content Marketing
“XQL Group's marketing expertise is a hallmark of the engagement.”
Stood up SEO as a new acquisition channel — domain rating 27 to 44, 50+ leads, and 88 articles in nine months.
ServicesSEO
“Their subject matter expertise is highly impressive.”
After six months of zero results from another agency, we delivered +70% Google clicks and grew AI-assistant traffic from 10 to 154/month in three months — and the first SQLs from SEO.
ServicesSEO · AI Search
Meta appointment funnels at scale — 466 leads and over 100 booked sales conversations from a single paid channel.
ServicesAppointment Funnels · Meta Ads
“They've brought structure, strong execution, and constant initiative.”
Set up marketing from zero — positioning, website, LinkedIn social selling, and an ABM campaign that landed four new clients fast.
ServicesFractional CMO · ABM · LinkedIn
“Their ability to combine strategic vision with hands-on execution was particularly valuable.”
Positioned a small studio in a niche AI-search category — recommended by LLMs for 2 commercial keywords, landing a big client in one month.
ServicesAI Search · AEO/GEO · Website
“They knew how to approach AI search practically, not just in theory.”
Recommended by every major AI assistant for 3 commercial keywords, plus a deal closed from Meta appointment funnels.
ServicesAI Search · Appointment Funnels
“What impressed us most was their deep specialization with software development companies.”
Positioned for an important commercial keyword and recommended by the major AI assistants within a single month.
ServicesAI Search · AEO/GEO
Took over marketing as their agency after an unsuccessful in-house run — GTM strategy, paid funnels, AI search, and LinkedIn delivered 75 leads and the first qualified pipeline.
ServicesFractional CMO · GTM Strategy · Appointment Funnels · AI Search
A targeted ABM campaign booked 13 conversations with ICP accounts and opened three opportunities in two months.
ServicesABM
Repositioned the agency, revamped the site, and built appointment funnels that booked qualified intro calls at just $34 each.
ServicesAppointment Funnels · Positioning · Website
A custom AI-assistant paid funnel produced 76 leads and 34 booked appointments at $123 per call with an ICP.
ServicesAppointment Funnels · Meta Ads
Meta appointment funnels delivered 35 leads at a $42 CPL and closed two deals on modest spend.
ServicesAppointment Funnels · Meta Ads
Thanks to XQL Group's efforts, we've seen a 207% increase in web traffic and an improvement in domain rating from 12 to 45. The team has successfully optimized our SEO strategy and gained around 160 backlinks. Overall, they're responsive and thorough in their project management.
Since working with XQL Group, our domain rating has improved from 27 to 44. In addition, we've seen a 15% increase in monthly traffic within nine months. The team completes work on time and within the agreed budget. Moreover, their subject matter expertise is highly impressive.
XQL Group's efforts have resulted in 44 leads from paid campaigns and improved web traffic from Germany by 5x. The team is responsive, quickly surfaces issues, and communicates regularly through chats and virtual meetings. Their expertise and proactiveness have impressed our team.
Organic traffic has increased by 10–15% each month, and we have started receiving our first inbound requests. XQL Group's optimization tips have also helped improve keyword rankings, and internal stakeholders are impressed with the team's collaborative approach.
XQL Group has successfully defined a clear marketing strategy and established our company's unique value proposition. The team has also helped hire critical specialists for our marketing team. They are communicative and organized, and their expertise in the tech industry is impressive.
Thanks to XQL Group's efforts, we have defined our marketing strategy and hired key developers for our website. The team has launched retargeting campaigns on LinkedIn and developed a strong content marketing strategy. XQL Group's marketing expertise is a hallmark of the engagement.
They were not just talking about AI search in theory; they knew how to approach it practically.
What impressed us most was their deep specialization in working with software development companies.
They've brought structure, strong execution, and constant initiative to improve outcomes.
They operated with the discipline and initiative of an internal senior marketer.
Their ability to combine strategic vision with hands-on execution was particularly valuable.
Their focus on results and true interest in making things work set them apart.
XQL Group's project management was exemplary.
The quality of their work is consistently high.
Four, usually: which clinical or scientific segment to win first, how the product is bought and reimbursed, what evidence you need and in what sequence to earn adoption, and how to say any of it within your cleared claims. Those decisions shape everything downstream, and leaving them unresolved is what stalls a company with strong technology. We work through them with you and your regulatory and MLR function, then build positioning, focus, and a motion that follow from the answers.
No. We do not make medical claims, we are not a clinical or regulatory authority, and we do not set your regulatory or reimbursement strategy, your evidence, your regulatory team, and your MLR function do. What we do is build the go-to-market and marketing around those, anchoring positioning to your cleared claims and evidence, and we run everything in coordination with your regulatory and MLR review. We make the market understand your value within the claims you can make; we do not generate or judge the science or the clearances.
Often decisively. For many devices, diagnostics, and digital-health products, whether and how the product is reimbursed can determine adoption regardless of clinical merit, and it shapes the buyer, the economics, and the message. We factor the reimbursement pathway into the positioning, the segment focus, and the access-and-economic story, in coordination with your team, so the go-to-market speaks to the people who approve spend, not just the clinicians who use the product. Ignoring reimbursement is one of the most common ways a strong product stalls.
Tightly, because evidence is what earns adoption here, and it paces the whole motion. What you can claim, which segments you can credibly target, and how KOLs and payers respond all depend on the evidence you have and are generating. We help sequence the go-to-market against your evidence roadmap, leading where the evidence is strongest, building credibility as it matures, and never getting ahead of what you are cleared to say, so marketing and evidence advance together rather than in conflict.
The buyer is a skeptical, evidence-driven, multi-stakeholder committee; the cycle is long and evidence-gated; reimbursement can decide adoption; every claim is regulated; and trust outweighs cleverness. A commercial SaaS GTM, built for a self-serve or fast committee sale with free claims, simply does not fit. We bring the transferable discipline, positioning, segment focus, model, motion, attribution, but adapt it to regulation, reimbursement, evidence, and the compliance boundary, which is what this sector actually requires.
We move in weeks, not quarters. You get a resolved GTM foundation, positioning within cleared claims, segment and ICP focus, the business-model and reimbursement view, the evidence strategy, and a credibility-first motion, plus the compliant assets and channel plan to run it, all wired to your CRM for long-cycle attribution and cleared through MLR. Fast enough to focus this cycle's effort. It is the work behind turning strong technology into adoption and tracked revenue across the 60+ B2B tech companies and $30M+ in marketing-led revenue we have delivered.
Bring your offer, channels, and revenue goals. We'll show you where the biggest growth constraint is and what to build next.
For B2B tech companies selling complex expertise to serious buyers.
I’m Danylo, founder of XQL. For 9+ years I’ve helped B2B tech companies turn technical expertise into pipeline — 60+ clients and $30M+ in CRM-tracked revenue.
30 minutes, no deck. Bring your offer, channels, and revenue goals — I’ll come with a read on where your biggest growth constraint is and what to build next.
